LOXL2 and Hepatic fibrosis: We show here that inhibition of LOXL2 activity during progressive liver fibrosis leads to increased accumulation of MoMFs within the liver parenchyma, particularly in the vicinity (up to 15 μ) of fibrotic collagen fibrils.